You have 9 free searches left this month | to do more

atezolizumab

Atezolizumab is a drug used to treat Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, and other conditions. Atezolizumab is being actively studied in 327 studies and prior, has been studied in 42.

Top SponsorsTop SitesTop Investigators
Hoffmann-La RocheAsan Medical CenterAslaug Helland
National Cancer Institute (NCI)Seoul National University HospitalDwight Owen
Genentech, Inc.Samsung Medical CenterGulam Manji
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • Cutaneous Melanoma
  • Atezolizumab
  • Houston, Texas
    Houston Methodist Hospital
2021-12-28
Dec 28, 2021
W
Not yet recruiting
  • Stage II Melanoma
  • Atezolizumab
  • +2 more
  • Duarte, California
  • +5 more
2022-03-15
Mar 15, 2022
H
Recruiting
  • Rectal Neoplasms
  • Rectal Cancer
  • Radiotherapy
  • +4 more
  • Shanghai, China
    Zhongshan Hospital Fudan University
2022-03-28
Mar 28, 2022
I
Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
2022-03-29
Mar 29, 2022
M
Not yet recruiting
  • Solid Tumor
  • Atezolizumab
  • +3 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
2022-03-29
Mar 29, 2022
M
Not yet recruiting
  • Recurrent Glioblastoma
  • Recurrent Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-31
Mar 31, 2022
M
Recruiting
  • Hepatocellular Carcinoma
  • Resectable Hepatocellular Carcinoma
  • Atezolizumab
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2022-02-10
Feb 10, 2022
G
Recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
2022-02-25
Feb 25, 2022
D
Active, not recruiting
  • Breast Cancer
  • Atezolizumab
  • Stereotactic radiosurgery (SRS)
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2021-12-27
Dec 27, 2021
H
Recruiting
  • Hepatocellular Carcinoma
  • Selinexor Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
2022-03-23
Mar 23, 2022
T
Active, not recruiting
  • Breast Cancer
  • Amsterdam, Netherlands
  • +3 more
2022-03-21
Mar 21, 2022
W
Recruiting
  • Extensive-stage Small Cell Lung Cancer
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-12-09
Dec 9, 2021
H
Active, not recruiting
  • Melanoma
  • Beijing City, China
  • +2 more
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • HER2-positive Metastatic Breast Cancer
  • Central Nervous System Metastases
  • ATEZOLIZUMAB
  • +2 more
  • Chicago, Illinois
  • +1 more
2022-03-14
Mar 14, 2022
G
Recruiting
  • Locally Advanced Cervical Cancer
  • Atezolizumab
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
2022-02-15
Feb 15, 2022
I
Recruiting
  • Solid Tumor
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden Hospital NHS Foundation Trust
2022-03-31
Mar 31, 2022
S
Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Atezolizumab
  • Stanford, California
    Stanford University
2021-06-30
Jun 30, 2021
N
Recruiting
  • Small Cell Lung Cancer Recurrent
  • Atezolizumab
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center
2022-04-04
Apr 4, 2022
D
Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-09-20
Sep 20, 2021
A
Recruiting
  • Colorectal Cancer
  • Atezolizumab
  • Essen, Germany
    Westdeutsches Tumorzentrum
2022-02-14
Feb 14, 2022
M
Not yet recruiting
  • Locally Advanced Osteosarcoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
U
Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Atezolizumab
  • Essen, Germany
    University Hospital Essen
2021-10-06
Oct 6, 2021
U
Not yet recruiting
  • Squamous Cell Carcinoma
  • Urinary Tract Cancer
  • Atezolizumab
  • (no location specified)
2021-09-07
Sep 7, 2021
U
Not yet recruiting
  • NSCLC Stage IV
  • NSCLC, Recurrent
  • Atezolizumab
  • Fairway, Kansas
  • +1 more
2022-01-20
Jan 20, 2022
M
Completed
  • Urothelial/Bladder Cancer, Nos
  • Atezolizumab
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2022-03-07
Mar 7, 2022